Latest Advisory

  • SYSTEM MAINTENANCE

    SYSTEM MAINTENANCE

    Read more

  • FDA Advisory No. 2017-281 || Public Health Warning Against the Use of Unregistered Household/Urban Pesticide Products (Batch 18)

    FDA Advisory No. 2017-281 || Public Health Warning Against the Use of Unregistered Household/Urban Pesticide Products (Batch 18)

    Read more

  • FDA cites PNP partnership

    FDA cites PNP partnership

    Read more

  • FDA Advisory No. 2017-282 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 66)

    FDA Advisory No. 2017-282 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 66)

    Read more

  • FDA Advisory No. 2017-283 || Voluntary Recall of Diamond Burr with Coarse and Extra-Coarse Grain (Pursuant to System)

    FDA Advisory No. 2017-283 || Voluntary Recall of Diamond Burr with Coarse and Extra-Coarse Grain (Pursuant to System)

    Read more

  • FDA Advisory No. 2017-284 || New Food and Drug Action Center (FDAC) Telephone Lines

    FDA Advisory No. 2017-284 || New Food and Drug Action Center (FDAC) Telephone Lines

    Read more

  • FDA Advisory No. 2017-280 || Public Health Warning Against the Use of Unregistered Household/Urban Pesticide Products (Batch 17)

    FDA Advisory No. 2017-280 || Public Health Warning Against the Use of Unregistered Household/Urban Pesticide Products (Batch 17)

    Read more

  • FDA Advisory No. 2017-278 || Public Health Warning Against the Use of Counterfeit Cosmetic Products (Batch 5)

    FDA Advisory No. 2017-278 || Public Health Warning Against the Use of Counterfeit Cosmetic Products (Batch 5)

    Read more

  • FDA Advisory No. 2017-279 || Public Health Warning Against the Use of Unregistered Household/Urban Pesticide Products (Batch 16)

    FDA Advisory No. 2017-279 || Public Health Warning Against the Use of Unregistered Household/Urban Pesticide Products (Batch 16)

    Read more

  • FDA Advisory No. 2017-277 || Public Health Warning Against the Use of UnnotifiedToy and Childcare Article (TCCAs) Products (Batch 10)

    FDA Advisory No. 2017-277 || Public Health Warning Against the Use of UnnotifiedToy and Childcare Article (TCCAs) Products (Batch 10)

    Read more

  • FDA Advisory No. 2017-273 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 64)

    FDA Advisory No. 2017-273 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 64)

    Read more

  • FDA Advisory No. 2017-276 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Supplements:

    FDA Advisory No. 2017-276 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Supplements:

    Read more

  • FDA Advisory No. 2017-275 || Public Health Warning Against HEALING GALING for Promoting and Selling the Following Unregistered Food Products with Therapeutic Claims:

    FDA Advisory No. 2017-275 || Public Health Warning Against HEALING GALING for Promoting and Selling the Following Unregistered Food Products with Therapeutic Claims:

    Read more

  • FDA Advisory No. 2017-274 || Lifting the Advisory of SUPER™ SUPER COFFEE 3in1 ORIGINAL under FDA Advisory No. 2017-264, Subject “Public Health Warning Against the Purchase and Consumption of the Unregistered Food Products”

    FDA Advisory No. 2017-274 || Lifting the Advisory of SUPER™ SUPER COFFEE 3in1 ORIGINAL under FDA Advisory No. 2017-264, Subject “Public Health Warning Against the Purchase and Consumption of the Unregistered Food Products”

    Read more

  • FDA Advisory No. 2017-272 || Public Health Warning on Art Coloring Products with Detected Levels of Lead (Batch 2)

    FDA Advisory No. 2017-272 || Public Health Warning on Art Coloring Products with Detected Levels of Lead (Batch 2)

    Read more

  • FDA Advisory 2017-271 || Public Health Warning Against the Purchase and Use of Unregistered Medical Device Product One Step Cassette Style HIV 1+2 Rapid Screen Test (whole blood) from Online Sellers and other Unauthorized Distributors

    FDA Advisory 2017-271 || Public Health Warning Against the Purchase and Use of Unregistered Medical Device Product One Step Cassette Style HIV 1+2 Rapid Screen Test (whole blood) from Online Sellers and other Unauthorized Distributors

    Read more

  • FDA Advisory No. 2017-268 || Public Health Warning Against Unapproved and Misleading Advertisements and Promotion of Quantumin Plus

    FDA Advisory No. 2017-268 || Public Health Warning Against Unapproved and Misleading Advertisements and Promotion of Quantumin Plus

    Read more

  • FDA Advisory No. 2017-270 || Invitation to Present Submitted Petitions and Corresponding Evidences in connection with the Re-certification of Contraceptive Products

    FDA Advisory No. 2017-270 || Invitation to Present Submitted Petitions and Corresponding Evidences in connection with the Re-certification of Contraceptive Products

    Read more

  • FDA Advisory No. 2017-266 || Public Health Warning Against the Use of Unnotified Toy and Childcare Article (TCCAs) Products (Batch 9)

    FDA Advisory No. 2017-266 || Public Health Warning Against the Use of Unnotified Toy and Childcare Article (TCCAs) Products (Batch 9)

    Read more

  • FDA Advisory No. 2017-267 || Public Health Warning Against the Use of Unregistered Household/Urban Pesticide Products (Batch 15)

    FDA Advisory No. 2017-267 || Public Health Warning Against the Use of Unregistered Household/Urban Pesticide Products (Batch 15)

    Read more

FDA assures Transparency in Contraceptives Review

The Food and Drugs Administration (FDA) recently assured the public that the evaluation and reevaluation of contraceptives, including those covered by a Supreme Court order, “is aboveboard and transparent”. It also said that the results of the process “will be fully compliant with the standards set by the High Court”.

The assurance was issued by FDA Director-General Nela Charade Puno as the agency nears the completion of the review in line with the certification and recertification of some 50 contraceptives. Several of these contraceptives are covered by an SC order for recertification following a petition by a civic group.

FDA Circular No. 2017-011 

New Batch Notification Form and Procedure

 

I. RATIONALE

  Pursuant to Section 5 (Reengineering of Systems and Procedures) of Republic Act No. 9485, otherwise known as the Anti-Red Tape Act of 2007, All offices and agencies which provide frontline services are hereby mandated to regularly undertake time and motion studies, undergo evaluation and improvement of their transaction systems and procedures and re-engineer the same if deemed necessary to reduce bureaucratic red tapeand processing time".

Postponement of the Conduct of Pharmacovigilance Regulations and Guidelines for PV Office Seminar

Please be informed that the conduct of the Pharmacovigilance Regulations and Guidelines for PV Office Seminar on 12-13 October, is POSTPONED and moved to 15-16 November 2017, due to non-availability of resource speakers from the Center for Drug Regulation and Research

Attachments:
Download this file (Announcement.pdf)Announcement.pdf

FDA Circular No. 2017-010

Subject:  New Collection Policy and Procedure

I. Rationale

Republic Act No. 9485, also known as Anti-Red Tape Act of 2007, was enacted to improve efficiency in the delivery of government service to the public and to establish effective practices aimed at the prevention of graft and corruption. This law mandates all government agencies and officers to take appropriate measures to promote transparency with regard to the manner of transacting with the public

to continue reading download attachment...

 

Share Us on

Submit to FacebookSubmit to Google PlusSubmit to Twitter